18th Expert Committee: Expert reviews

• Anaesthesia and muscle relaxant sections (Review) Adults and Children (Reviewer 1)
  pdf, 88kb
• Anaesthesia and muscle relaxant sections (Review) Adults and Children (Reviewer 2)
  pdf, 42kb
• Antacids and other antiulcer medicines (Deletion) Adults and Children (Reviewer 1)
  pdf, 83kb
• Antacids and other antiulcer medicines (Deletion) Adults and Children (Reviewer 2)
  pdf, 153kb
• Antineoplastic, immunosuppressives and medicines used in palliative care (Review) Children (Reviewer 1)
  pdf, 330kb
• Antineoplastic, immunosuppressives and medicines used in palliative care (Review) Children (Reviewer 2)
  pdf, 89kb
• Antithrombotic (Review) Children (Reviewer 1)
  pdf, 83kb
• Antithrombotic (Review) Children (Reviewer 2)
  pdf, 85kb
• Antivirals (Review) Adults and Children (Reviewer 1)
  pdf, 81kb
• Antivirals (Review) Adults and Children (Reviewer 2)
  pdf, 67kb
• Artesunate + amodiaquine fixed-dose combination (Inclusion) Adults and Children (Reviewer 1)
  pdf, 71kb
• Artesunate + amodiaquine fixed-dose combination (Inclusion) Adults and Children (Reviewer 2)
  pdf, 76kb
• Bisoprolol (Inclusion) Adults (Reviewer 1) -- Section 12
  pdf, 156kb
• Bisoprolol (Inclusion) Adults (Reviewer 2) -- Section 12
  pdf, 34kb
• Bisoprolol (Inclusion) Adults (Reviewer 1) -- Section 12.4
  pdf, 147kb
• Bisoprolol (Inclusion) Adults (Reviewer 2) -- Section 12.4
  pdf, 31kb
• Chlorhexidine (Change of formulation) Children (Reviewer 1)
  pdf, 83kb
• Chlorhexidine (Change of formulation) Children (Reviewer 2)
  pdf, 54kb
• Codeine (Deletion) Children (Reviewer 1)
  pdf, 84kb
• Darunavir (Inclusion) Adults and Children (Reviewer 1)
  pdf, 82kb
• Darunavir (Inclusion) Adults and Children (Reviewer 2)
  pdf, 85kb
• Dermatological medicines (Review) Adults and Children (Reviewer 1)
  pdf, 93kb
• Dermatological medicines (Review) Adults and Children (Reviewer 2)
  pdf, 48kb
• Dihydroartemisinin + piperaquine (Inclusion) Adults and Children (Reviewer 1)
  pdf, 94kb
• Dihydroartemisinin + piperaquine (Inclusion) Adults and Children (Reviewer 2)
  pdf, 79kb
• DL-methionine (Deletion) Adults (Reviewer 1)
  pdf, 77kb
• DL-methionine (Deletion) Adults (Reviewer 2)
  pdf, 87kb
• DMARDs (Review) Children (Reviewer 1)
  pdf, 122kb
• DMARDs (Review) Children (Reviewer 2)
  pdf, 254kb
• Ether (Re-instatement) Adults and Children (Reviewer 1)
  pdf, 88kb
• Ethinylestradiol (Deletion) Adults (Reviewer 1)
  pdf, 172kb
• Ethinylestradiol (Deletion) Adults (Reviewer 2)
  pdf, 93kb
• Etravirine (Inclusion) Adults (Reviewer 1)
  pdf, 84kb
• Etravirine (Inclusion) Adults (Reviewer 2)
  pdf, 95kb
• Etravirine (Inclusion) Adults (Reviewer 3)
  pdf, 95kb
• Fluoroquinolones (Review) Children (Reviewer 1)
  pdf, 90kb
• Gatifloxacin (Inclusion) Adults and Children (Reviewer 2)
  pdf, 83kb
• Glucagon (Inclusion) Adults and Children (Reviewer 1)
  pdf, 232kb
• Glucagon (Inclusion) Adults and Children (Reviewer 2)
  pdf, 81kb
• Ibuprofen (Review) Children (Reviewer 2)
  pdf, 68kb
• Imatinib (Inclusion) Children and Adolescents (Reviewer 1)
  pdf, 72kb
• Imatinib (Inclusion) Children and Adolescents (Reviewer 2)
  pdf, 84kb
• Isoniazid + pyridoxine + sulfamethoxazole + trimethoprim (New formulation) Adults (Reviewer 1)
  pdf, 84kb
• Isoniazid + pyridoxine + sulfamethoxazole + trimethoprim (New formulation) Adults (Reviewer 2)
  pdf, 79kb
• Loperamide (Inclusion) and codeine phosphate (Deletion) Adults (Reviewer 1)
  pdf, 77kb
• Loperamide (Inclusion) and codeine phosphate (Deletion) Adults (Reviewer 2)
  pdf, 79kb
• Mannitol (Review) Children (Reviewer 1)
  pdf, 82kb
• Mannitol (Review) Children (Reviewer 2)
  pdf, 93kb
• Medroxyprogesterone acetate (Deletion) Adults (Reviewer 1)
  pdf, 87kb
• Medroxyprogesterone acetate (Deletion) Adults (Reviewer 2)
  pdf, 82kb
• Midazolam (Inclusion) Adults and Children (Reviewer 1)
  pdf, 79kb
• Miltefosine (Inclusion) Adults and Children (Reviewer 1)
  pdf, 87kb
• Miltefosine (Inclusion) Adults and Children (Reviewer 2)
  pdf, 109kb
• Misoprostol (New formulation) (for specific PPH treatment indication) Adults (Reviewer 1)
  pdf, 85kb
• Misoprostol (New formulation) (for specific PPH treatment indication) Adults (Reviewer 2)
  pdf, 102kb
• Misoprostol (New formulation) (for the prevention of PPH) Adults (Reviewer 2)
  pdf, 95kb
• Neglected tropical diseases (Review) Children (Reviewer 2)
  pdf, 236kb
• Norethisterone (Deletion) Adults (Reviewer 1)
  pdf, 85kb
• Oral iron chelation therapy (Review) Children (Reviewer 1)
  pdf, 112kb
• Oral iron chelation therapy (Review) Children (Reviewer 2)
  pdf, 88kb
• Oral lead chelation therapy (Review) Children (Reviewer 1)
  pdf, 112kb
• Oxytocin (Change of formulation) Adults (Reviewer 2)
  pdf, 84kb
• Oral lead chelation therapy (Review) Children (Reviewer 2)
  pdf, 86kb
• Paclitaxel and docetaxel (Inclusion) Adults (Reviewer 1)
  pdf, 86kb
• Paclitaxel and docetaxel (Inclusion) Adults (Reviewer 2)
  pdf, 96kb
• Promethazine (Deletion) Adults and Children (Reviewer 1)
  pdf, 55kb
• Promethazine (Deletion) Adults and Children (Reviewer 2)
  pdf, 82kb
• Propofol (Inclusion) Adults (Reviewer 1)
  pdf, 80kb
• Propofol (Inclusion) Adults (Reviewer 2)
  pdf, 79kb
• Psychotherapeutic medicines (Review) Adults and Children (Reviewer 2)
  pdf, 76kb
• Pyronaridine + artesunate fixed-dose combination (Inclusion) Adults and Children (Reviewer 1)
  pdf, 97kb
• Pyronaridine + artesunate fixed-dose combination (Inclusion) Adults and Children (Reviewer 2)
  pdf, 95kb
• Raltegravir (Inclusion) Adults (Reviewer 2)
  pdf, 91kb
• Review of the evidence comparing insulin (human or animal) with analogue insulins (Review) Adults and Children (Reviewer 1)
  pdf, 87kb
• Review of the evidence comparing insulin (human or animal) with analogue insulins (Review) Adults and Children (Reviewer 2)
  pdf, 33kb
• Review of the evidence for H. Pylori treatment regimens: Section 17.1 (Review) Adults and Children (Reviewer 1)
  pdf, 75kb
• Review of the evidence for H. Pylori treatment regimens: Section 17.1 (Review) Adults and Children (Reviewer 3)
  pdf, 75kb
• Review of the use of oral hypoglycaemic agents in children (Review) Children (Reviewer 1)
  pdf, 174kb
• Review of the use of oral hypoglycaemic agents in children (Review) Children (Reviewer 2)
  pdf, 101kb
• Salbutamol (Deletion) Adults and Children (Reviewer 1)
  pdf, 71kb
• Sickle cell disease (New section) Adults and Children (Reviewer 1)
  pdf, 86kb
• Sickle cell disease (New section) Adults and Children (Reviewer 2)
  pdf, 71kb
• Sodium calcium edetate and penicillamine (Review) Children (Reviewer 1)
  pdf, 94kb
• Spironolactone (Review) Children (Reviewer 1)
  pdf, 80kb
• Succimer (Review) Children (Reviewer 1)
  pdf, 71kb
• Succimer (Review) Children (Reviewer 2)
  pdf, 81kb
• Sulfamethoxazole + trimethoprim (New formulation) Adults (Reviewer 1)
  pdf, 89kb
• Sulfamethoxazole + trimethoprim (New formulation) Adults (Reviewer 2)
  pdf, 77kb
• Tranexamic acid (Inclusion) Adults (Reviewer 1)
  pdf, 131kb
• Tranexamic acid (Inclusion) Adults (Reviewer 2)
  pdf, 172kb
• Zinc sulfate (New formulation) Children (Reviewer 1)
  pdf, 57kb
• Zinc sulfate (New formulation) Children (Reviewer 2)
  pdf, 78kb